Fig. 2From: Long-term safety and effectiveness of velaglucerase alfa in Gaucher disease: 6-year interim analysis of a post-marketing surveillance in JapanPlatelet counts for Japanese patients with GD treated with velaglucerase alfa. Box and whisker chart showing the change in platelet count in the patients with GD following treatment with velaglucerase alfa over time. GD Gaucher diseaseBack to article page